PRA's Draft Rules Could Push UK Funded Reinsurance Capital to 10% of Liabilities

Why It Matters

The proposed capital uplift targets a niche but growing segment of the UK insurance market that has been used to manage longevity risk and improve balance‑sheet efficiency. By raising the capital charge to about 10% of underlying liabilities, the PRA could force insurers to re‑price or abandon Funded Re arrangements, potentially increasing the cost of annuity products for consumers. The change also touches on cross‑border regulatory dynamics, as many funded reinsurers operate from Bermuda under Solvency II equivalence. A higher UK capital requirement may create a competitive mismatch, prompting a shift toward domestic solutions or alternative risk‑transfer mechanisms. Beyond the immediate financial impact, the proposal signals a broader regulatory trend toward tighter scrutiny of long‑duration, asset‑backed risk‑transfer structures. If the PRA’s approach is adopted, it could set a precedent for other jurisdictions to reassess the capital treatment of similar products, influencing global reinsurance markets and the design of future longevity‑risk solutions.

Key Takeaways

• PRA's CP8/26 paper proposes raising Funded Re capital from 2‑4% to ~10% of annuity liabilities
• Amendment focuses on the Counterparty Default Adjustment (CDA) and treats Funded Re like a collateralised loan
• Higher charge could increase costs for UK insurers and reduce reliance on Bermuda‑based funded reinsurers
• Consultation period runs through the remainder of 2026, with industry feedback expected on the quantum of the increase
• Potential shift toward traditional reinsurance or capital‑market solutions if the rule is adopted

Pulse Analysis

The PRA’s draft represents a decisive regulatory pivot that could reshape the longevity‑risk landscape in the UK. Historically, Funded Re has been prized for its ability to off‑load long‑dated annuity liabilities without the heavy capital drag associated with traditional reinsurance. By imposing a near‑10% capital charge, the regulator is effectively re‑pricing that convenience, forcing insurers to internalise a larger share of the risk. This move aligns with the PRA’s broader post‑2022 focus on granular risk assessment, but it also risks stifling innovation in the market for long‑duration risk transfer.

From a competitive standpoint, the proposal may erode the cost advantage of Bermuda‑based reinsurers, whose business models rely on lower capital requirements under Solvency II equivalence. If UK cedants are forced to hold additional capital for the same risk, the net benefit of sourcing protection offshore diminishes, potentially prompting a re‑allocation of capital toward domestic reinsurers or alternative structures such as longevity swaps. Insurers with sizable annuity books will need to model the impact on solvency ratios and may accelerate the development of internal capital models that can mitigate the higher charge.

Looking ahead, the consultation outcome will be a bellwether for how regulators balance financial stability with market efficiency. A modest adjustment to the CDA could preserve the utility of Funded Re while addressing the PRA’s concerns about concentration risk. Conversely, a full‑scale adoption of the 10% charge could trigger a wave of product redesigns, higher annuity pricing, and a re‑evaluation of the role of offshore reinsurers in the UK market. Stakeholders should monitor the PRA’s final rule closely, as it will likely influence not only UK insurers but also the global dialogue on capital treatment for long‑duration risk‑transfer instruments.